Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0000950170-24-129462

Chief Legal Officer sold 6,407 shares at $1.01 ($6,471)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Wilson Mark Andrew Chief Legal Officer 2024-11-19 Sale −6,407 $1.01 $6,471 218,856 D
Open-market sales · 6,407 sh · avg $1.01 · $6,471
Loading xslF345X05/ownership.xml…